Nicola S. Vos

510 total citations
17 papers, 308 citations indexed

About

Nicola S. Vos is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Nicola S. Vos has authored 17 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 13 papers in Cardiology and Cardiovascular Medicine and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Nicola S. Vos's work include Coronary Interventions and Diagnostics (13 papers), Acute Myocardial Infarction Research (12 papers) and Cardiac Imaging and Diagnostics (6 papers). Nicola S. Vos is often cited by papers focused on Coronary Interventions and Diagnostics (13 papers), Acute Myocardial Infarction Research (12 papers) and Cardiac Imaging and Diagnostics (6 papers). Nicola S. Vos collaborates with scholars based in Netherlands, France and Russia. Nicola S. Vos's co-authors include Giovanni Amoroso, Mark S. Patterson, Ton Slagboom, Maarten A. Vink, Jean‐Paul R. Herrman, René J. van der Schaaf, Nick D. Fagel, Jasper E. Kal, Pieter Siebenga and Fabian O. Kooij and has published in prestigious journals such as American Heart Journal, British Journal of Anaesthesia and International Journal of Cardiology.

In The Last Decade

Nicola S. Vos

16 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicola S. Vos Netherlands 8 272 236 107 47 10 17 308
Paul Coady United States 5 215 0.8× 243 1.0× 104 1.0× 44 0.9× 2 0.2× 13 300
Atsuo Namiki Japan 9 200 0.7× 165 0.7× 94 0.9× 114 2.4× 3 0.3× 33 279
Ryota Sakurai United States 11 327 1.2× 194 0.8× 153 1.4× 135 2.9× 5 0.5× 28 371
Andrea Erriquez Italy 8 350 1.3× 301 1.3× 303 2.8× 44 0.9× 34 398
Anthony Spaedy United States 7 183 0.7× 158 0.7× 123 1.1× 44 0.9× 10 238
Pietro Laforgia Italy 8 89 0.3× 216 0.9× 55 0.5× 76 1.6× 3 0.3× 19 241
Nikolaus Löffelhardt Germany 9 180 0.7× 158 0.7× 94 0.9× 71 1.5× 14 219
Toshiharu Fujii Japan 10 148 0.5× 211 0.9× 84 0.8× 87 1.9× 48 309
Jung-Won Suh South Korea 5 208 0.8× 252 1.1× 56 0.5× 64 1.4× 10 307
Thaddeus R. Tolleson United States 8 410 1.5× 432 1.8× 108 1.0× 128 2.7× 14 543

Countries citing papers authored by Nicola S. Vos

Since Specialization
Citations

This map shows the geographic impact of Nicola S. Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicola S. Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicola S. Vos more than expected).

Fields of papers citing papers by Nicola S. Vos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicola S. Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicola S. Vos. The network helps show where Nicola S. Vos may publish in the future.

Co-authorship network of co-authors of Nicola S. Vos

This figure shows the co-authorship network connecting the top 25 collaborators of Nicola S. Vos. A scholar is included among the top collaborators of Nicola S. Vos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicola S. Vos. Nicola S. Vos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Vos, Nicola S., et al.. (2023). Pharmacogenetics to Personalize Dosing of Tricyclic Antidepressants in Major Depressive Disorder: A Randomized Clinical Trial (PITA study). European Psychiatry. 66(S1). S93–S93. 1 indexed citations
2.
Vos, Nicola S., René J. van der Schaaf, Giovanni Amoroso, et al.. (2023). EXpansion of stents after intravascular lithoTripsy versus conventional predilatation in CALCified coronary arteries. International Journal of Cardiology. 386. 24–29. 4 indexed citations
3.
Vos, Nicola S., René van der Schaaf, Giovanni Amoroso, et al.. (2021). Two-Year Clinical Outcomes of the REVELATION Study: Sustained Safety and Feasibility of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction. ˜The œJournal of invasive cardiology. 34(1). E39–E42. 19 indexed citations
4.
Fagel, Nick D., Giovanni Amoroso, Maarten A. Vink, et al.. (2021). One‐year mortality in NSTEMI patients is unaffected by timing of PCI within the first week of admission: Results of a real‐world cohort analysis. Catheterization and Cardiovascular Interventions. 98(5). E661–E667.
5.
Fagel, Nick D., Giovanni Amoroso, Maarten A. Vink, et al.. (2021). An immediate or early invasive strategy in non-ST-elevation acute coronary syndrome: The OPTIMA-2 randomized controlled trial. American Heart Journal. 234. 42–50. 10 indexed citations
6.
Vos, Nicola S., Nick D. Fagel, Giovanni Amoroso, et al.. (2019). Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction. JACC: Cardiovascular Interventions. 12(17). 1691–1699. 139 indexed citations
7.
Vos, Nicola S., Giovanni Amoroso, Maarten A. Vink, et al.. (2018). Prehospital Prasugrel Versus Ticagrelor in Real-World Patients With ST-Elevation Myocardial Infarction Referred for Primary PCI: Procedural and 30-Day Outcomes.. PubMed. 30(12). 431–436. 5 indexed citations
8.
9.
Grundeken, Maik J., Nicola S. Vos, Alexander Ijsselmuiden, et al.. (2017). One-Year Clinical Outcomes of Patients Presenting With ST-Segment Elevation Myocardial Infarction Caused by Bifurcation Culprit Lesions Treated With the Stentys Self-Apposing Coronary Stent: Results From the APPOSITION III Study.. PubMed. 29(8). 253–258. 4 indexed citations
10.
11.
Koch, Karel T., Maik J. Grundeken, Nicola S. Vos, et al.. (2015). One-year clinical outcomes of the STENTYS Self-Apposing¨ coronary stent in patients presenting with ST-segment elevation myocardial infarction: results from the APPOSITION III registry. EuroIntervention. 11(3). 264–271. 17 indexed citations
12.
Vos, Nicola S., René J. van der Schaaf, Giovanni Amoroso, et al.. (2015). REVascularization with paclitaxEL‐coated balloon angioplasty versus drug‐eluting stenting in acute myocardial infarcTION—A randomized controlled trial: Rationale and design of the REVELATION trial. Catheterization and Cardiovascular Interventions. 87(7). 1213–1221. 7 indexed citations
13.
Amoroso, Giovanni, Nicola S. Vos, Jan A.S. Van der Heyden, et al.. (2015). A prospective, postmarket study with the Mguard Prime Embolic Protection Stent in ST‐segment elevation myocardial infarction: The International MGuard Prime Observational Study (IMOS Prime). Catheterization and Cardiovascular Interventions. 86(S1). S28–33. 1 indexed citations
14.
Vink, Maarten A., Nicola S. Vos, Maurits T. Dirksen, et al.. (2015). Recurrent Myocardial Infarction After Primary Percutaneous Coronary Intervention in Multivessel Coronary Disease Is Primarily Related to Stent Failure. Journal of Interventional Cardiology. 28(6). 523–530. 2 indexed citations
15.
Vos, Nicola S., Maurits T. Dirksen, Maarten A. Vink, et al.. (2014). Safety and feasibility of a PAclitaxel-eluting balloon angioplasty in Primary Percutaneous coronary intervention in Amsterdam (PAPPA): one-year clinical outcome of a pilot study. EuroIntervention. 10(5). 584–590. 42 indexed citations
16.
Vos, Nicola S., et al.. (2014). [Recurrent neutropenia due to adulterated cocaine].. PubMed. 158. A7430–A7430. 1 indexed citations
17.
Kooij, Fabian O., et al.. (2012). Automated reminders decrease postoperative nausea and vomiting incidence in a general surgical population. British Journal of Anaesthesia. 108(6). 961–965. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Coady Breakdown of academic impact, for papers by Atsuo Namiki Breakdown of academic impact, for papers by Ryota Sakurai Breakdown of academic impact, for papers by Andrea Erriquez Breakdown of academic impact, for papers by Anthony Spaedy Breakdown of academic impact, for papers by Pietro Laforgia Breakdown of academic impact, for papers by Nikolaus Löffelhardt Breakdown of academic impact, for papers by Toshiharu Fujii Breakdown of academic impact, for papers by Jung-Won Suh Breakdown of academic impact, for papers by Thaddeus R. Tolleson
Rankless by CCL
2026